Ned Sacktor Selected Research

Neurocognitive Disorders (Clerambault Syndrome)

6/2021	Assessment, prevalence, and correlates of frailty among middle-aged adults with HIV in rural Uganda.
1/2021	Neurocognitive Complications of HIV Infection in Low-Income Countries.
1/2020	Neurocognitive Effects of Antiretroviral Initiation Among People Living With HIV in Rural Uganda.
12/2019	Interleukin-6 is associated with mortality and neuropsychiatric outcomes in antiretroviral-naïve adults in Rakai, Uganda.
1/2019	Effect of HIV Subtype and Antiretroviral Therapy on HIV-Associated Neurocognitive Disorder Stage in Rakai, Uganda.
1/2019	White matter damage, neuroinflammation, and neuronal integrity in HAND.
1/2019	Vitamin D is not associated with HIV-associated neurocognitive disorder in Rakai, Uganda.
1/2019	Caregiver versus self-reported activities of daily living among HIV-positive persons in Rakai, Uganda.
1/2018	Neuropsychological phenotypes among men with and without HIV disease in the multicenter AIDS cohort study.
1/2018	Changing clinical phenotypes of HIV-associated neurocognitive disorders.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ned Sacktor Research Topics

Disease

25	Cognitive Dysfunction 01/2022 - 04/2002
24	Neurocognitive Disorders (Clerambault Syndrome) 06/2021 - 05/2008
15	HIV Infections (HIV Infection) 01/2019 - 10/2003
10	AIDS Dementia Complex 02/2008 - 04/2002
8	Dementia (Dementias) 01/2021 - 04/2003
8	Inflammation (Inflammations) 08/2020 - 06/2010
8	Acquired Immunodeficiency Syndrome (AIDS) 01/2019 - 12/2002
7	Infections 02/2020 - 04/2002
4	Atrophy 01/2017 - 06/2011
3	Neuroinflammatory Diseases 01/2020 - 06/2014
3	Peripheral Nervous System Diseases (PNS Diseases) 01/2020 - 12/2002
2	Neuralgia (Stump Neuralgia) 01/2022 - 01/2020
2	Polyneuropathies (Polyneuropathy) 01/2022 - 12/2002
2	Pain (Aches) 01/2022 - 01/2021
2	Nervous System Diseases (Neurological Disorders) 10/2014 - 10/2012
1	Neurologic Manifestations (Neurological Manifestations) 02/2020
1	Headache (Headaches) 12/2019
1	Leukocytosis (Pleocytosis) 01/2019
1	Hypercholesterolemia 01/2019
1	Hyperinsulinism (Hyperinsulinemia) 01/2019
1	Insulin Resistance 01/2019
1	Encephalitis (Encephalitis, Rasmussen) 01/2018
1	Myositis (Idiopathic Inflammatory Myopathies) 04/2017
1	Inclusion Body Myositis 04/2017
1	Hypertension (High Blood Pressure) 01/2017
1	Diabetes Mellitus 01/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2016
1	Obesity 01/2015
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2013
1	Virus Diseases (Viral Diseases) 10/2010
1	Intravenous Substance Abuse 07/2006
1	Transverse Myelitis (Necrotizing Myelitis) 02/2006

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 08/2020 - 09/2007
5	RNA (Ribonucleic Acid)IBA 01/2019 - 11/2004
5	Proteins (Proteins, Gene)FDA Link 01/2019 - 02/2006
4	N-acetylaspartate (N-acetyl aspartate)IBA 01/2019 - 04/2005
3	Choline (Choline Chloride)IBA 01/2020 - 02/2010
3	Interleukin-6 (Interleukin 6)IBA 12/2019 - 01/2015
3	LipidsIBA 04/2016 - 05/2008
3	Apolipoproteins E (ApoE)IBA 02/2015 - 07/2006
3	Pharmaceutical PreparationsIBA 07/2006 - 12/2002
2	Viral ProteinsIBA 01/2017 - 01/2008
2	AdiponectinIBA 01/2017 - 01/2015
2	Biological ProductsIBA 01/2016 - 08/2007
2	Minocycline (Cyclops)FDA LinkGeneric 12/2014 - 01/2013
2	SphingolipidsIBA 10/2013 - 05/2008
2	Macrophage Colony-Stimulating FactorIBA 10/2010 - 01/2007
2	Protons (Proton)IBA 02/2010 - 04/2005
1	Amitriptyline (Elavil)FDA LinkGeneric 01/2022
1	Opioid Analgesics (Opioids)IBA 01/2022
1	efavirenz (Sustiva)FDA Link 02/2020
1	8-hydroxyefavirenzIBA 02/2020
1	Pain-FreeIBA 01/2020
1	Inosine Monophosphate (IMP)IBA 01/2020
1	fibrin fragment D (D-dimer)IBA 12/2019
1	HDL LipoproteinsIBA 01/2019
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2019
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2019
1	C-PeptideIBA 01/2019
1	Vitamin D FDA LinkGeneric 01/2019
1	Ritonavir (Norvir)FDA Link 01/2019
1	ElementsIBA 01/2019
1	Inositol (Myoinositol)IBA 01/2019
1	Insulin (Novolin)FDA Link 01/2019
1	Atazanavir Sulfate (Reyataz)FDA Link 01/2019
1	Paroxetine (Paxil)FDA LinkGeneric 01/2018
1	Biological FactorsIBA 01/2018
1	Fluconazole (Zonal)FDA LinkGeneric 01/2018
1	AutoantibodiesIBA 04/2017
1	Creatine Kinase (Creatine Phosphokinase)IBA 04/2017
1	nucleotidaseIBA 04/2017
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2017
1	CytokinesIBA 01/2017
1	Platelet-Derived Growth FactorIBA 01/2017
1	platelet-derived growth factor AIBA 01/2017
1	InterferonsIBA 01/2017
1	Trans-Activators (Trans-Acting Factor)IBA 10/2016
1	Glutamic Acid (Glutamate)FDA Link 04/2016
1	AdipokinesIBA 01/2015
1	Neurotransmitter Agents (Neurotransmitter)IBA 12/2014
1	DNA (Deoxyribonucleic Acid)IBA 01/2012
1	Hemoglobins (Hemoglobin)IBA 10/2011
1	Immunologic Factors (Immunomodulators)IBA 10/2010
1	CreatineIBA 02/2010
1	HydrogenIBA 02/2010
1	Anti-Retroviral Agents (Antiretroviral Agents)IBA 02/2008
1	Monoamine Oxidase (MAO)IBA 11/2007
1	Selegiline (E250)FDA LinkGeneric 11/2007
1	abacavir (Ziagen)FDA Link 03/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2007
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2007
1	Chemotactic FactorsIBA 01/2007
1	ApolipoproteinsIBA 07/2006
1	Opiate AlkaloidsIBA 07/2006
1	Apolipoprotein E4IBA 07/2006

Therapy/Procedure

23	Highly Active Antiretroviral Therapy (HAART) 01/2021 - 04/2002
18	Therapeutics 01/2022 - 04/2002
5	Art Therapy 01/2021 - 01/2017
3	Activities of Daily Living (ADL) 01/2020 - 01/2018
1	Pain Management 01/2022